Honegger A - Search Results

1

T-cell receptor gene transfer exclusively to human CD8(+) cells enhances tumor cell killing.

Zhou Q, Schneider IC, Edes I, Honegger A, Bach P, Schönfeld K, Schambach A, Wels WS, Kneissl S, Uckert W, Buchholz CJ. Zhou Q, et al. Among authors: honegger a. Blood. 2012 Nov 22;120(22):4334-42. doi: 10.1182/blood-2012-02-412973. Epub 2012 Aug 16. Blood. 2012. PMID: 22898597 Free article.

2

Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv.

Friedel T, Hanisch LJ, Muth A, Honegger A, Abken H, Plückthun A, Buchholz CJ, Schneider IC. Friedel T, et al. Among authors: honegger a. Protein Eng Des Sel. 2015 Apr;28(4):93-106. doi: 10.1093/protein/gzv005. Epub 2015 Feb 25. Protein Eng Des Sel. 2015. PMID: 25715658 Free article.

3

Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control.

Schmid M, Ernst P, Honegger A, Suomalainen M, Zimmermann M, Braun L, Stauffer S, Thom C, Dreier B, Eibauer M, Kipar A, Vogel V, Greber UF, Medalia O, Plückthun A. Schmid M, et al. Among authors: honegger a. Nat Commun. 2018 Jan 31;9(1):450. doi: 10.1038/s41467-017-02707-6. Nat Commun. 2018. PMID: 29386504 Free PMC article.

4

The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.

Honegger A, Malebranche AD, Röthlisberger D, Plückthun A. Honegger A, et al. Protein Eng Des Sel. 2009 Mar;22(3):121-34. doi: 10.1093/protein/gzn077. Epub 2009 Jan 10. Protein Eng Des Sel. 2009. PMID: 19136675 Free article.

5

Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.

Nieba L, Honegger A, Krebber C, Plückthun A. Nieba L, et al. Among authors: honegger a. Protein Eng. 1997 Apr;10(4):435-44. doi: 10.1093/protein/10.4.435. Protein Eng. 1997. PMID: 9194169 Free article.

6

Biophysical properties of human antibody variable domains.

Ewert S, Huber T, Honegger A, Plückthun A. Ewert S, et al. Among authors: honegger a. J Mol Biol. 2003 Jan 17;325(3):531-53. doi: 10.1016/s0022-2836(02)01237-8. J Mol Biol. 2003. PMID: 12498801

7

Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach.

Ewert S, Honegger A, Plückthun A. Ewert S, et al. Among authors: honegger a. Biochemistry. 2003 Feb 18;42(6):1517-28. doi: 10.1021/bi026448p. Biochemistry. 2003. PMID: 12578364

8

Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.

Röthlisberger D, Honegger A, Plückthun A. Röthlisberger D, et al. Among authors: honegger a. J Mol Biol. 2005 Apr 8;347(4):773-89. doi: 10.1016/j.jmb.2005.01.053. J Mol Biol. 2005. PMID: 15769469

9

Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.

Kügler M, Stein C, Schwenkert M, Saul D, Vockentanz L, Huber T, Wetzel SK, Scholz O, Plückthun A, Honegger A, Fey GH. Kügler M, et al. Among authors: honegger a. Protein Eng Des Sel. 2009 Mar;22(3):135-47. doi: 10.1093/protein/gzn079. Epub 2009 Feb 1. Protein Eng Des Sel. 2009. PMID: 19188138 Free article.

10

Selection for improved protein stability by phage display.

Jung S, Honegger A, Plückthun A. Jung S, et al. Among authors: honegger a. J Mol Biol. 1999 Nov 19;294(1):163-80. doi: 10.1006/jmbi.1999.3196. J Mol Biol. 1999. PMID: 10556036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters